Carnosinase-1 overexpression, but not aerobic exercise training, affects the development of diabetic nephropathy in

Inge Everaert1, Junling He2, Maxime Hanssens1

  • 1Department of Movement and Sports Sciences, Ghent University, Ghent, Belgium.

Insights

Overexpressing the human carnosinase-1 (hCN1) enzyme accelerated kidney damage in mice, while exercise training did not impact diabetic nephropathy (DN). Lower histidine-containing dipeptides (HCD) levels correlated with advanced DN, suggesting HCD stimulation as a potential therapeutic strategy.

Area of Science:

  • Nephrology
  • Metabolic Diseases
  • Biochemistry

Background:

  • Circulating histidine-containing dipeptides (HCD) influence diabetes and early diabetic nephropathy (DN).
  • The impact of interventions altering HCD on advanced DN remains unclear.
  • Investigating HCD's role in advanced DN is crucial for therapeutic development.

Purpose of the Study:

  • To determine if interventions altering histidine-containing dipeptides (HCD) affect advanced diabetic nephropathy (DN).
  • To compare the effects of aerobic exercise and hCN1 overexpression on DN markers.
  • To explore the link between HCD levels and renal damage in DN.

Main Methods:

  • BTBR ob/ob mice underwent aerobic exercise or hCN1 overexpression.
  • Diabetes and DN markers were compared between intervention groups and controls (ob/ob and wild-type mice).
  • Plasma HCD levels were analyzed following acute exercise and hCN1 manipulation.

Main Results:

  • Chronic aerobic exercise did not alter diabetes or DN progression.
  • hCN1 overexpression accelerated hyperlipidemia and worsened albuminuria, mesangial expansion, and glomerular hypertrophy.
  • Plasma, kidney, and muscle HCD levels were lower in ob/ob mice compared to wild-type mice.
  • Plasma and kidney HCD were lower in hCN1-overexpressing ob/ob mice, unaffected by exercise.

Conclusions:

  • Advanced glomerular damage is accelerated by hCN1 overexpression, not prevented by exercise.
  • Diabetic nephropathy development is closely linked to renal HCD availability.
  • Stimulating renal HCD levels may represent a future therapeutic strategy for DN.